rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2003-10-27
|
pubmed:abstractText |
To compare the incidence of heart failure in individuals with type 2 diabetes receiving thiazolidinediones (TZDs) versus other oral antihyperglycemic agents.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0149-5992
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2983-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14578227-Cohort Studies,
pubmed-meshheading:14578227-Diabetes Mellitus, Type 2,
pubmed-meshheading:14578227-Heart Failure,
pubmed-meshheading:14578227-Incidence,
pubmed-meshheading:14578227-Insurance, Health,
pubmed-meshheading:14578227-Proportional Hazards Models,
pubmed-meshheading:14578227-Retrospective Studies,
pubmed-meshheading:14578227-Risk Factors,
pubmed-meshheading:14578227-Thiazolidinediones
|
pubmed:year |
2003
|
pubmed:articleTitle |
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study.
|
pubmed:affiliation |
Policy Analysis, Brookline, Massachusetts 02455, USA. tdelaea@pai2.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|